In stroke patients, the LP was shown to be the relevant pathway in the progression of ischemic brain damage [12, 15–17] with studies highlighting MBL [18, 19] and ficolin-3 [15], two different LP recognition molecules, as independent predictors of ischemic stroke outcome. Here, FCN3 is linked to stroke disorder.